The Office of the United States Trade Representative will hold a public hearing on September 22, 2026, to discuss the Section 301 investigation into Germany's pharmaceutical policies.

2026-09-22

The Office of the United States Trade Representative will hold a public hearing on September 22, 2026, to discuss the Section 301 investigation into Germany's pharmaceutical policies.